Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
TSE:4572
Price:
398 JPY
2.58%
Market Closed
Updated:
May 31, 2024
Carna Biosciences Inc
Total Liabilities & Equity
|
Carna Biosciences Inc
Total Liabilities & Equity Peer Comparison
Comparables:
2309
S
2395
2370
4880
2183
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc
TSE:4572
|
Total Liabilities & Equity
¥4.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Total Liabilities & Equity
¥67.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Total Liabilities & Equity
¥76.3B
|
CAGR 3-Years
27%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Medinet Co Ltd
TSE:2370
|
Total Liabilities & Equity
¥6.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-6%
|
|
|
CellSource Co Ltd
TSE:4880
|
Total Liabilities & Equity
¥6.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Total Liabilities & Equity
¥17.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
21%
|
See Also
What is Carna Biosciences Inc's Total Liabilities & Equity?
Total Liabilities & Equity
4.3B
JPY
4.3B
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Total Liabilities & Equity amounts to 4.3B JPY.
What is Carna Biosciences Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
9%
9%
Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Carna Biosciences Inc have been -3% over the past three years , 20% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
